The global supplement market hit $209 billion in 2025 and is heading toward $393 billion by 2033. In the U.S. alone it cleared $72.9 billion. Three things are driving this:

AG1 built a $1.2 billion company selling one product, in one flavor, through one channel. No retail. No product line. No TV ads. Just a green powder, sold direct, built on trust.

Founder Chris Ashenden kept getting sick and was eventually prescribed 50 pills a day. He spent years building one drink that replaced them all. That founder story gave the brand emotional weight no ad budget can manufacture. He then renamed the category entirely — instead of "greens powder," AG1 called itself foundational nutrition. One scoop covers your nutritional bases. Done. That shift from ingredients to outcomes made the product feel like a daily non-negotiable, not an optional extra.

AG1 also bootstrapped for 12 years before taking a cent of outside investment, hitting $160M in revenue with no external funding. When they finally raised, they did it at a $1.2B valuation. The rebrand from Athletic Greens to AG1 in 2022 was equally sharp — clean, minimal packaging designed by New York studio Creech turned a supplement into something that looked like a luxury product.

Podcasts as the core channel.AG1 spent over$2.2 million per monthon podcast sponsorships — Joe Rogan, Andrew Huberman, Tim Ferriss, and hundreds more. But these weren't standard ad reads. Hosts became genuine advocates: Ferriss became an investor, Huberman became a medical advisor. Rogan reportedly earns $10M/year to promote it. Repeated endorsements from trusted voices built credibility that no banner ad can replicate.

Custom landing pages per influencer.Every major podcaster had their own landing page written for their specific audience. Huberman's page spoke to neuroscience nerds. Rogan's page hit energy and performance. The ad and the page felt like one continuous conversation, not a redirect.

Affiliate program at scale. AG1 paid affiliates 20–50% per sale, turning bloggers, YouTubers, and content creators into a self-sustaining sales force. The #AthleticGreens hashtag hit 86 million TikTok views — almost entirely organic.

Premium pricing as positioning. At $79/month on subscription, AG1 is 2–3x more expensive than competitors. That's intentional. In health, a higher price signals higher quality. The subscription came with a welcome kit worth over $80 in accessories — making the first month feel like a steal.

AG1's gross margin sits at approximately 75%, which means they can afford aggressive customer acquisition costs. The welcome kit (canister, scoop, shaker, Vitamin D supply) reduces early cancellations by making subscribers feel invested from Day 1. Once a morning scoop becomes a habit, people don't cancel.

The formula has been updated 52 times. In 2025 under new CEO Kat Cole, AG1 launched its first major reformulation in nine years, added travel-stick packaging, and announced four clinical trials to back its health claims. By 2024, AG1 was generating $600 million in annual revenue from a single product.

IM8 became the fastest-growing supplement brand ever, hitting $108M in annual revenue just 11 months after launch in December 2024. AG1 took nearly a decade to hit $100M. IM8 did it in less than one year.

The brand started with a simple conversation: serial entrepreneur Danny Yeung and David Beckham agreed that taking 16 separate supplements every morning was ridiculous. Their solution — replace all 16 with one daily drink. But the real differentiator wasn't Beckham's face. It was the science.

Beckham spent a full year in labs with Mayo Clinic experts and NASA's former Chief Scientist before the product launched. The result was two products:

The scientific advisory board includes NASA's former Chief Scientist, a Mayo Clinic cardiolo, and researchers from Yale and the University of Florida. IM8 even sent ingredients to the International Space Station for an aging study with the University of Oxford. That's not a PR stunt — it's credibility made tangible.

Brand identity was a direct challenge to AG1. Where AG1 owns green, IM8 owns red. Where AG1 is warm and welcoming, IM8 is bold and confrontational — publishing head-to-head lab comparisons and calling out the market leader by name.

Equity over endorsements.David Beckham received4% equityin IM8 — not a one-time fee. He's a co-founder with real skin in the game, which consumers can sense. At 50, his physique is the brand's most persuasive proof point.

Athletes as shareholders, not just sponsors. World No. 1 tennis player Aryna Sabalenka joined as a shareholder and global ambassador. Her single US Open Instagram post generated 233 million views at zero ad spend. NBA star Giannis Antetokounmpo is also an ambassador. IM8 doesn't chase lifestyle influencers — it targets credible performers in their fields.

1,200 active ads running simultaneously.IM8 had over 1,200 live Meta ads at any given time. Each ad is short, shot in selfie/iPhone style, and opens with empathy framing:"It's not your fault you feel exhausted at 2pm". Clicks never go to the homepage — they go to a custom advertorial that mirrors the ad's message and goes deeper with doctor quotes and ingredients.

The checkout is engineered for retention. Free gifts worth $80 (frother, water bottle, longevity pack) are added at checkout. The default option is a 90-day subscription, not monthly. This locks in habits before anyone considers cancelling, adds more cash upfront, and creates an extra billing cycle per year compared to monthly.

Product seeding as a performance channel. IM8 sends over 500 free samples monthly — but only to athletes and trainers who already buy premium supplements. Every sample goes to someone likely to convert. Conversions are tracked like paid ads. Almost all major ambassador partnerships are now inbound — people reach out to IM8 to be involved.

The AI ad that broke the internet. At the 2025 US Open, IM8 ran an AI-generated ad on the Times Square billboard starring Aryna Sabalenka — 95% AI, 5% real footage. It hit 40 million Instagram views in one day, 233 million total.

Year One internal forecast was $30M — IM8 exceeded it 3.6x. The product is priced at $89, but the brand frames this against the $290 it would cost to buy all 16 supplements separately. The $89 feels like the obvious, smarter.

1. Enter a proven market, don't create one.
AG1 didn't invent vitamins. IM8 didn't invent gut health. They both entered categories where people were already spending money — then did it better. Find the dominant brand in your space. Read their worst reviews. That's your brief.

2. Pick one product and go deep.
AG1 has one product. IM8 has two. Focus let every dollar of marketing reinforce the same promise. Spreading across too many products dilutes.

3. Build trust before you run ads.
AG1 spent years cultivating podcast hosts before scaling ad spend. IM8 got NSF certification and assembled a scientific board before launch. Layer credibility first — even if it's just three micro-influencers and a money-back.

4. Make subscription the default.
Both brands make one-time purchase the more expensive, less attractive option. Subscriptions come pre-selected, cheaper, and loaded with free gifts. Design your checkout so the subscription is the obvious choice.

5. Match your ad to your landing page.
The Sweat Equity Podcast calls this funnel congruency: if your ad talks about 3pm energy crashes, every page after the click should talk about 3pm energy crashes. A broken funnel wastes ad.

6. Test more creative, more often.
IM8 ran 1,200 ads at once. Most brands run 10. You can't predict which ad wins — you can only test until you find it, then scale hard behind it. Build a pipeline of content through affiliates, seeding, or a creator.

7. Own a visual identity.
IM8 owns red. AG1 owns green. Being instantly recognizable is free marketing every time someone sees your product. Look at your category and find the color, shape, or aesthetic that nobody else has claimed.

The playbook is hiding in plain sight. Both of these brands decoded it. Now it's yours to use.